Publication Name	World Journal of Stem Cells
Manuscript ID	92116
Country	Türkiye

Received	2024-01-15 17:40
Peer-Review Started	2024-01-15 17:40
To Make the First Decision
Return for Revision	2024-01-29 20:58
Revised	2024-02-26 20:16
Second Decision	2024-04-22 23:31
Accepted by Journal Editor-in-Chief	2024-04-25 00:54
Accepted by Executive Editor-in-Chief	2024-05-09 05:28
Articles in Press	2024-05-09 05:28
Publication Fee Transferred
Edit the Manuscript by Language Editor	2024-05-16 19:45
Typeset the Manuscript	2024-05-23 11:56
Publish the Manuscript Online	2024-06-25 10:11

ISSN	1948-0210 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Neurosciences
Manuscript Type	Clinical Trials Study
Article Title	Safety and efficiency of Wharton’s Jelly-derived mesenchymal stem cell administration in patients with traumatic brain injury: First results of phase I study
Manuscript Source	Invited Manuscript
All Author List	Serdar Kabatas, Erdinç Civelek, Osman Boyalı, Gülseli Berivan Sezen, Omer Ozdemir, Yeliz Bahar-Ozdemir, Necati Kaplan, Eyüp Can Savrunlu and Erdal Karaöz
ORCID	Author(s) ORCID Number Serdar Kabatas http://orcid.org/0000-0003-2691-6861 Erdinç Civelek http://orcid.org/0000-0002-3988-4064 Osman Boyalı http://orcid.org/0000-0002-2500-1718 Gülseli Berivan Sezen http://orcid.org/0000-0001-9129-5470 Omer Ozdemir http://orcid.org/0000-0003-3783-0203 Necati Kaplan http://orcid.org/0000-0001-5672-0566 Eyüp Can Savrunlu http://orcid.org/0000-0001-9022-200X Erdal Karaöz http://orcid.org/0000-0002-9992-833X
Funding Agency and Grant Number
Corresponding Author	Serdar Kabatas, MD, Full Professor, Department of Neurosurgery, University of Health Sciences Turkey, Gaziosmanpaşa Training and Research Hospital, Karayolları Mahallesi, Osmanbey Caddesi 616. Sokak No. 10, Gaziosmanpaşa, Istanbul 34360, Türkiye. kabatasserdar@hotmail.com
Key Words	Traumatic brain injury; Wharton Jelly; Stem cell therapy; Transplantation; Mesenchymal stem cell
Core Tip	Traumatic brain injury (TBI) is a disease that particularly affects the young population and causes serious neurological deficits. Current treatment options do not provide the hoped-for improvement in patients. For this reason, many studies are being conducted on new treatment options for TBI. In our phase I study, we presented data showing that mesenchymal stem cell applications can be a safe and effective treatment option in this patient group.
Publish Date	2024-06-25 10:11
Citation	<p>Kabatas S, Civelek E, Boyalı O, Sezen GB, Ozdemir O, Bahar-Ozdemir Y, Kaplan N, Savrunlu EC, Karaöz E. Safety and efficiency of Wharton’s Jelly-derived mesenchymal stem cell administration in patients with traumatic brain injury: First results of phase I study. <i>World J Stem Cells</i> 2024; 16(6): 641-655</p>
URL	https://www.wjgnet.com/1948-0210/full/v16/i6/641.htm
DOI	https://dx.doi.org/10.4252/wjsc.v16.i6.641

Full Article (PDF)	WJSC-16-641-with-cover.pdf
CONSORT 2010 Statement	92116-CONSORT-2010-statement.pdf
Manuscript File	92116_Auto_Edited-YJP-Language editing-Webster J-Clear.docx
Answering Reviewers	92116-answering-reviewers.pdf
Audio Core Tip	92116-audio.mp3
Biostatistics Review Certificate	92116-biostatistics-statement.pdf
Clinical Trial Registration Statement	92116-clinical-trial-registration-statement.pdf
Conflict-of-Interest Disclosure Form	92116-conflict-of-interest-statement.pdf
Copyright License Agreement	92116-copyright-assignment.pdf
Signed Informed Consent Form(s) or Document(s)	92116-informed-consent-statement.pdf
Institutional Review Board Approval Form or Document	92116-institutional-review-board-statement.pdf
Non-Native Speakers of English Editing Certificate	92116-non-native-speakers.pdf
Peer-review Report	92116-peer-reviews.pdf
Journal Editor-in-Chief Review Report	92116-journal-editor-in-chief.pdf
Scientific Misconduct Check	92116-scientific-misconduct-check.png
Scientific Editor Work List	92116-scientific-editor-work-list.pdf
CrossCheck Report	92116-crosscheck-report.pdf